Your Complete Wegovy to Mounjaro Switching Guide
Can You Switch From Wegovy to Mounjaro: The Switch & Save Advantage
When patients ask "can you switch from Wegovy to Mounjaro," the answer is definitively yes—with proper medical supervision. The Switch & Save approach recognises that many patients find Mounjaro's dual GIP and GLP-1 receptor mechanism offers different benefits compared to Wegovy's single GLP-1 action. Some patients report improved tolerability with Mounjaro's tirzepatide formulation, whilst others appreciate the potential cost savings. The key advantage of switching through EverydayMeds is continuity—you maintain the same trusted pharmacy relationship whilst transitioning between treatments.
Our Switch & Save programme specifically addresses the common concerns patients have when considering whether you can switch from Wegovy to Mounjaro safely. Rather than starting from scratch with a new pharmacy, our existing patients can seamlessly transition their prescription-only medicine supply. This continuity ensures no gaps in treatment, maintains your dosing history, and provides consistent clinical oversight throughout the switching process.
Pricing Comparison: Switch From Wegovy to Mounjaro Savings
Understanding the cost implications is crucial when patients evaluate whether they can switch from Wegovy to Mounjaro. Our Mounjaro pricing structure offers several advantages over traditional Wegovy costs. Single pens start from £79.99 for starter doses, with our Intro Duo bundle (containing your first two months' supply) priced at £139.99. New customers can apply discount code FIRST40 at checkout, whilst returning customers use DOSE25 to reach these competitive prices. The 2-pen bundles provide particular value for patients establishing their optimal maintenance dose.
The financial benefits extend beyond individual pen pricing when you switch from Wegovy to Mounjaro through our service. Our Ultimate Stability Trio provides three months of maintenance supply for £269.99, ensuring consistent medication availability without multiple ordering requirements. This pricing structure, combined with our discount codes, delivers genuine savings compared to traditional prescription channels whilst maintaining the same clinical standards and cold-chain delivery protocols.
Clinical Evidence Supporting Mounjaro for Weight Management
The SURMOUNT clinical trial programme demonstrates tirzepatide's effectiveness for weight management, with participants achieving significant weight loss alongside reduced-calorie diet and increased physical activity. In SURMOUNT-1, patients taking the highest dose experienced average weight loss of approximately 20.9% at 72 weeks, as reported by Jastreboff et al., NEJM, 2022. These results support why many patients choose to switch from Wegovy to Mounjaro under medical supervision.
However, individual results may vary, and patients considering whether they can switch from Wegovy to Mounjaro should understand that clinical trial outcomes don't assurance personal results. The decision to switch should be based on individual tolerance, effectiveness, and clinical factors rather than trial comparisons alone, as different study designs and populations make direct comparisons inappropriate.
How Mounjaro Works Differently From Wegovy
Mounjaro (tirzepatide) represents a dual approach to weight management, targeting both GIP and GLP-1 receptors simultaneously. This dual mechanism may provide enhanced appetite suppression and improved glucose control compared to single-hormone approaches. The medication works by slowing gastric emptying, promoting satiety after smaller meals, and potentially reducing food cravings through effects on brain appetite centres. Unlike Wegovy's single GLP-1 action, this dual approach offers a different pathway for patients who haven't achieved optimal results with their current treatment. Understanding these mechanistic differences helps patients make informed decisions about whether they can switch from Wegovy to Mounjaro effectively.
Your Switching Process: From Assessment to Delivery
The process for patients who want to switch from Wegovy to Mounjaro begins with our 3-minute online clinical assessment, specifically designed to evaluate switching suitability. Our GPhC-registered prescribers (#9012878) review your current Wegovy usage, dose, tolerance, and reasons for switching within our standard 3 working days, or 24 hours with express review. Once approved, your Mounjaro prescription ships via next-day delivery using temperature-controlled cold-chain logistics. The assessment captures your current dose equivalency to ensure appropriate starting doses, and our prescribers provide specific guidance on timing your switch to maintain therapeutic continuity throughout the transition process.
Storage and Practical Considerations for Your Switch
When you switch from Wegovy to Mounjaro, storage requirements remain similar—both require refrigeration at 2-8°C before first use. However, Mounjaro can be stored at room temperature for up to 21 days once removed from the fridge, compared to Wegovy's 6-week room temperature tolerance. Both medications use pre-filled pens with similar injection techniques, making the practical transition straightforward for most patients. The dose escalation schedule differs slightly, with Mounjaro following a 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, 15mg progression compared to Wegovy's pathway. Our prescribers provide detailed conversion guidance to ensure patients understand their new dosing schedule and injection timing requirements.
Why Patients Successfully Switch From Wegovy to Mounjaro
Many patients find that switching from Wegovy to Mounjaro addresses specific challenges they experienced with their previous treatment. Some report improved gastrointestinal tolerance with tirzepatide's formulation, whilst others appreciate the dual-hormone mechanism's different approach to appetite regulation. The flexibility of having both options available through EverydayMeds means patients aren't locked into a single treatment approach. Cost considerations also influence switching decisions, particularly for patients funding their own treatment who want to optimise their monthly medication expenses.
The psychological benefit of knowing you can switch from Wegovy to Mounjaro easily reduces treatment anxiety and increases long-term adherence. Patients report feeling more confident about their weight management journey when they know alternative options remain available through their existing pharmacy relationship, rather than requiring complete provider changes.
Complete Your Switch With Expert Support
Ready to explore whether you can switch from Wegovy to Mounjaro? Start your clinical assessment today at our dedicated weight loss collection, where our prescribers can evaluate your switching suitability and provide personalised dose conversion guidance. New customers should apply code FIRST40 at checkout, whilst returning customers use DOSE25 to access our competitive pricing. Our GPhC-registered pharmacy (#9012878) ensures clinical excellence throughout your switching process, with next-day delivery maintaining treatment continuity. Take advantage of our Switch & Save approach and discover whether Mounjaro's dual-hormone mechanism better supports your weight management goals alongside reduced-calorie diet and increased physical activity. Visit https://everydaymeds.co.uk/collections/weight-loss to begin your switching assessment today.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
